KAYA17 logo

KAYA17 jobs and careers

About KAYA17

KAYA17 is a Point-Of-Care Testing developer which has developed a 15-minute rapid Covid-19 saliva test. This test has an accuracy of 98% sensitivity and 100% specificity. Kaya17 is currently pending FDA approval for EUA of an Antigen test, and should hear back early 2021.

Employees
11 to 50

Leadership

The top of KAYA17's org chart, with how many people report into each leader.

SD

Sulatha Dwarakanath, Ph.D.

Founder & CEO

1 report

KSPhoto of Kevin T. Seltzer

Kevin T. Seltzer

Chief Financial Officer